Download
1-s2.0-S1876034120305025-main.pdf 262,56KB
WeightNameValue
1000 Titel
  • Re-evaluation of retested nucleic acid-positive cases in recovered COVID-19 patients: Report from a designated transfer hospital in Chongqing, China
1000 Autor/in
  1. Chen, Yan |
  2. Bai, Weizhi |
  3. Liu, Bin |
  4. Huang, Jian |
  5. Laurent, Irakoze |
  6. Chen, Feng |
  7. Deng, Wuquan |
  8. Xiao, Xiaoqiu |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-06-07
1000 Erschienen in
1000 Quellenangabe
  • 13(7):932-934
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/j.jiph.2020.06.008 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275981/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, Hubei Province, China [1], a large number of confirmed cases met the discharge criteria (one of which is two consecutive negative nucleic acid tests with an interval of at least 24 h) [2]. Previous studies have paid more attention to the epidemic situation of COVID-19 and patient diagnosis and treatment. Close attention also should be paid to the discharged patients. Surprisingly, a previous follow-up reported that some patients’ nucleic acid retest results were positive again after discharge [3]. Factors impacting these follow-up test results should be further investigated. Since the first confirmed case was diagnosed in our hospital (Chongqing Emergency Medical Center, the designated transfer hospital) on February 4th, we confirmed a total of 17 cases. All patients infected with the novel coronavirus were transferred to a designated hospital in Southwest China’s Chongqing by ambulance with an inbuilt negative-pressure chamber [4]. In the follow-up examination of these patients, RT-PCR tests were conducted again 3 days after discharged from the designated hospital. Four patients showed recurrence of positive results after a few days of discharge. Thus, we examined these cases herein, aiming to provide information for policy formulation and modification of discharge plans.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Nucleic acid
lokal Retest
lokal Positive
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/Q2hlbiwgWWFu|https://frl.publisso.de/adhoc/uri/QmFpLCBXZWl6aGk=|https://frl.publisso.de/adhoc/uri/TGl1LCBCaW4=|https://frl.publisso.de/adhoc/uri/SHVhbmcsIEppYW4=|https://frl.publisso.de/adhoc/uri/TGF1cmVudCwgSXJha296ZQ==|https://frl.publisso.de/adhoc/uri/Q2hlbiwgRmVuZw==|https://frl.publisso.de/adhoc/uri/RGVuZywgV3VxdWFu|https://frl.publisso.de/adhoc/uri/WGlhbywgWGlhb3FpdQ==
1000 Label
1000 Förderer
  1. Chongqing University |
  2. Chongqing Science and Technology Commission |
  3. Yuzhong District |
1000 Fördernummer
  1. 2019CDYGYB020
  2. cstc2018jcyjAX0335zt
  3. 20180156
1000 Förderprogramm
  1. Fundamental Research Funds for the Central Universities
  2. Basic Research and Frontier Exploration
  3. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Chongqing University |
    1000 Förderprogramm Fundamental Research Funds for the Central Universities
    1000 Fördernummer 2019CDYGYB020
  2. 1000 joinedFunding-child
    1000 Förderer Chongqing Science and Technology Commission |
    1000 Förderprogramm Basic Research and Frontier Exploration
    1000 Fördernummer cstc2018jcyjAX0335zt
  3. 1000 joinedFunding-child
    1000 Förderer Yuzhong District |
    1000 Förderprogramm -
    1000 Fördernummer 20180156
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6421982.rdf
1000 Erstellt am 2020-07-20T07:35:55.875+0200
1000 Erstellt von 21
1000 beschreibt frl:6421982
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet Fri Oct 01 15:56:13 CEST 2021
1000 Objekt bearb. Fri Oct 01 15:56:13 CEST 2021
1000 Vgl. frl:6421982
1000 Oai Id
  1. oai:frl.publisso.de:frl:6421982 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source